Robert Townsend currently serves as the Sr. Director of Translational and Transformational Immunology Discovery at AbbVie, a position held since 2023. Previously, Robert was the Director of Cellular and Translational Immunology at EMD Serono, Inc. from 2017 to 2022, where responsibilities included overseeing target identification and validation for autoimmune disease therapies. At Bristol-Myers Squibb from 1998 to 2017, Robert progressed through multiple roles, including Group Director for Clinical Biomarkers, focusing on immunology, virology, and fibrosis. Earlier positions included research at Kimmel Cancer Institute, Du Pont Merck Pharmaceuticals, and Du Pont Pharmaceuticals, with significant contributions to immunology and the development of immunosuppressive agents. Robert earned a Ph.D. in Immunology from Temple University and a Bachelor's Degree in Biology and Anthropology from Duke University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices